Top

BMC Cancer

Published in:

Open Access 01-12-2023 | Breast Cancer | Research

Predicting acute radiation dermatitis in breast cancer: a prospective cohort study

Authors: Yuxiu Xie, Ting Hu, Renwang Chen, Haiyan Chang, Qiong Wang, Jing Cheng

Published in: BMC Cancer | Issue 1/2023

Abstract

Background

Acute radiation dermatitis (ARD) is one of the most common acute adverse reactions in breast cancer patients during and immediately after radiotherapy. As ARD affects patient quality of life, it is important to conduct individualized risk assessments of patients in order to identify those patients most at risk of developing severe ARD.

Methods

The data of breast cancer patients who received radiotherapy were prospectively collected and analyzed. Serum ferritin, high-sensitivity C-reactive protein (hs-CRP) levels, and percentages of lymphocyte subsets were measured before radiotherapy. ARD was graded (0–6 grade), according to the Oncology Nursing Society Skin Toxicity Scale. Univariate and multivariate logistic regression analyses were used and the odds ratio (OR) and 95% confidence interval (CI) of each factor were calculated.

Results

This study included 455 breast cancer patients. After radiotherapy, 59.6% and 17.8% of patients developed at least 3 (3+) grade and at least 4 (4+) grade ARD, respectively. Multivariate logistic regression analysis found that body mass index (OR: 1.11, 95% CI: 1.01–1.22), diabetes (OR: 2.70, 95% CI: 1.11–6.60), smoking (OR: 3.04, 95% CI: 1.15–8.02), higher ferritin (OR: 3.31, 95% CI: 1.78–6.17), higher hs-CRP (OR: 1.96, 95% CI: 1.02–3.77), and higher CD3 + T cells (OR: 2.99, 95% CI: 1.10–3.58) were independent risk factors for 4 + grade ARD. Based on these findings, a nomogram model of 4 + grade ARD was further established. The nomogram AUC was 0.80 (95% CI: 0.75–0.86), making it more discriminative than any single factor.

Conclusion

BMI, diabetes, smoking history, higher ferritin, higher hs-CRP, and higher CD3 + T cells prior to radiotherapy for breast cancer are all independent risk factors for 4 + grade ARD. The results can provide evidence for clinicians to screen out high-risk patients, take precautions and carefully follow up on these patients before and during radiotherapy.

Available only for authorised users

Siegel RL, Miller KD, Wagle NS, Jemal A. Cancer statistics, 2023. CA Cancer J Clin. 2023;73:17–48. https://doi.org/10.3322/caac.21763.CrossRefPubMed

Xia C, Dong X, Li H, Cao M, Sun D, He S, et al. Cancer statistics in China and United States, 2022: profiles, trends, and determinants. Chin Med J (Engl). 2022;135:584–90. https://doi.org/10.1097/CM9.0000000000002108.CrossRefPubMed

McGale P, Taylor C, Correa C, Cutter D, Duane F, Ewertz M, et al. Effect of radiotherapy after mastectomy and axillary surgery on 10-year recurrence and 20-year breast cancer mortality: meta-analysis of individual patient data for 8135 women in 22 randomised trials. Lancet. 2014;383:2127–35. https://doi.org/10.1016/s0140-6736(14)60488-8.CrossRefPubMed

Darby S, McGale P, Correa C, Taylor C, Arriagada R, Clarke M, et al. Effect of radiotherapy after breast-conserving surgery on 10-year recurrence and 15-year breast cancer death: meta-analysis of individual patient data for 10,801 women in 17 randomised trials. Lancet. 2011;378:1707–16. https://doi.org/10.1016/s0140-6736(11)61629-2.CrossRefPubMed

Singh M, Alavi A, Wong R, Akita S, Radiodermatitis. A review of our current understanding. Am J Clin Dermatol. 2016;17:277–92. https://doi.org/10.1007/s40257-016-0186-4.CrossRefPubMed

Ramadan M, Hetta HF, Saleh MM, Ali ME, Ahmed AA, Salah M. Alterations in skin microbiome mediated by radiotherapy and their potential roles in the prognosis of radiotherapy-induced dermatitis: a pilot study. Sci Rep. 2021;11:5179. https://doi.org/10.1038/s41598-021-84529-7.CrossRefPubMedPubMedCentral

Wang SL, Fang H, Song YW, Wang WH, Hu C, Liu YP, et al. Hypofractionated versus conventional fractionated postmastectomy radiotherapy for patients with high-risk breast cancer: a randomised, non-inferiority, open-label, phase 3 trial. Lancet Oncol. 2019;20:352–60. https://doi.org/10.1016/s1470-2045(18)30813-1.CrossRefPubMed

Allali S, Kirova Y. Radiodermatitis and Fibrosis in the context of breast Radiation Therapy: a critical review. Cancers (Basel). 2021;13. https://doi.org/10.3390/cancers13235928.

Lilla C, Ambrosone CB, Kropp S, Helmbold I, Schmezer P, von Fournier D, et al. Predictive factors for late normal tissue complications following radiotherapy for breast cancer. Breast Cancer Res Treat. 2007;106:143–50. https://doi.org/10.1007/s10549-006-9480-9.CrossRefPubMed

10.

Finkelstein S, Kanee L, Behroozian T, Wolf JR, van den Hurk C, Chow E, et al. Comparison of clinical practice guidelines on radiation dermatitis: a narrative review. Supportive care in cancer: official journal of the Multinational Association of Supportive Care in Cancer. 2022;30:4663–74. https://doi.org/10.1007/s00520-022-06829-6.CrossRefPubMed

11.

Liu L, Yang Y, Guo Q, Ren B, Peng Q, Zou L, et al. Comparing hypofractionated to conventional fractionated radiotherapy in postmastectomy breast cancer: a meta-analysis and systematic review. Radiation Oncol (London England). 2020;15:17. https://doi.org/10.1186/s13014-020-1463-1.CrossRef

12.

Andrade TRM, Fonseca MCM, Segreto HRC, Segreto RA, Martella E, Nazário ACP. Meta-analysis of long-term efficacy and safety of hypofractionated radiotherapy in the treatment of early breast cancer. Breast. 2019;48:24–31. https://doi.org/10.1016/j.breast.2019.08.001.CrossRefPubMed

13.

Jagsi R, Griffith KA, Boike TP, Walker E, Nurushev T, Grills IS, et al. Differences in the acute toxic Effects of breast radiotherapy by Fractionation schedule: comparative analysis of physician-assessed and patient-reported outcomes in a large Multicenter Cohort. JAMA Oncol. 2015;1:918–30. https://doi.org/10.1001/jamaoncol.2015.2590.CrossRefPubMed

14.

Hymes SR, Strom EA, Fife C. Radiation dermatitis: clinical presentation, pathophysiology, and treatment 2006. J Am Acad Dermatol. 2006;54:28–46. https://doi.org/10.1016/j.jaad.2005.08.054.CrossRefPubMed

15.

Smith AO, Ju W, Adzraku SY, Wenyi L, Yuting C, Qiao J, et al. Gamma Radiation Induce Inflammasome Signaling and Pyroptosis in Microvascular endothelial cells. J Inflamm Res. 2021;14:3277–88. https://doi.org/10.2147/jir.S318812.CrossRefPubMedPubMedCentral

16.

Hu JJ, Urbanic JJ, Case LD, Takita C, Wright JL, Brown DR, et al. Association between inflammatory biomarker C-Reactive protein and Radiotherapy-Induced Early adverse skin reactions in a Multiracial/Ethnic breast Cancer Population. J Clin oncology: official J Am Soc Clin Oncol. 2018;36:2473–82. https://doi.org/10.1200/jco.2017.77.1790.CrossRef

17.

Moreira AC, Mesquita G, Gomes MS. Ferritin: an inflammatory player keeping Iron at the Core of Pathogen-Host interactions. Microorganisms. 2020;8. https://doi.org/10.3390/microorganisms8040589.

18.

Ruddell RG, Hoang-Le D, Barwood JM, Rutherford PS, Piva TJ, Watters DJ, et al. Ferritin functions as a proinflammatory cytokine via iron-independent protein kinase C zeta/nuclear factor kappab-regulated signaling in rat hepatic stellate cells. Hepatology (Baltimore MD). 2009;49:887–900. https://doi.org/10.1002/hep.22716.CrossRefPubMed

19.

Kell DB, Pretorius E. Serum ferritin is an important inflammatory disease marker, as it is mainly a leakage product from damaged cells. Metallomics: Integr biometal Sci. 2014;6:748–73. https://doi.org/10.1039/c3mt00347g.CrossRef

20.

Sukiennicki GM, Marciniak W, Muszyńska M, Baszuk P, Gupta S, Białkowska K, et al. Iron levels, genes involved in iron metabolism and antioxidative processes and lung cancer incidence. PLoS ONE. 2019;14:e0208610. https://doi.org/10.1371/journal.pone.0208610.CrossRefPubMedPubMedCentral

21.

Chang VC, Cotterchio M, Khoo E. Iron intake, body iron status, and risk of breast cancer: a systematic review and meta-analysis. BMC Cancer. 2019;19:543. https://doi.org/10.1186/s12885-019-5642-0.CrossRefPubMedPubMedCentral

22.

Veldwijk MR, Seibold P, Botma A, Helmbold I, Sperk E, Giordano FA, et al. Association of CD4(+) Radiation-Induced Lymphocyte apoptosis with fibrosis and Telangiectasia after Radiotherapy in 272 breast Cancer patients with > 10-Year follow-up. Clin Cancer Res. 2019;25:562–72. https://doi.org/10.1158/1078-0432.CCR-18-0777.CrossRefPubMed

23.

Talbot CJ, Veldwijk MR, Azria D, Batini C, Bierbaum M, Brengues M, et al. Multi-centre technical evaluation of the radiation-induced lymphocyte apoptosis assay as a predictive test for radiotherapy toxicity. Clin Transl Radiat Oncol. 2019;18:1–8. https://doi.org/10.1016/j.ctro.2019.06.001.CrossRefPubMedPubMedCentral

24.

Xie Y, Wang Q, Hu T, Chen R, Wang J, Chang H, et al. Risk factors related to Acute Radiation Dermatitis in breast Cancer patients after Radiotherapy: a systematic review and Meta-analysis. Front Oncol. 2021;11:738851. https://doi.org/10.3389/fonc.2021.738851.CrossRefPubMedPubMedCentral

25.

Wright JL, Takita C, Reis IM, Zhao W, Lee E, Nelson OL, et al. Prospective evaluation of radiation-induced skin toxicity in a race/ethnically diverse breast cancer population. Cancer Med. 2016;5:454–64. https://doi.org/10.1002/cam4.608.CrossRefPubMedPubMedCentral

26.

Rattay T, Seibold P, Aguado-Barrera ME, Altabas M, Azria D, Barnett GC, et al. External validation of a predictive model for Acute skin Radiation Toxicity in the REQUITE breast cohort. Front Oncol. 2020;10:575909. https://doi.org/10.3389/fonc.2020.575909.CrossRefPubMedPubMedCentral

27.

Steele JR, Coltman CE, McGhee DE. Effects of obesity on breast size, thoracic spine structure and function, upper torso musculoskeletal pain and physical activity in women. J sport health Sci. 2020;9:140–8. https://doi.org/10.1016/j.jshs.2019.05.003.CrossRefPubMed

28.

Iyengar NM, Gucalp A, Dannenberg AJ, Hudis CA. Obesity and Cancer mechanisms: Tumor Microenvironment and inflammation. J Clin oncology: official J Am Soc Clin Oncol. 2016;34:4270–6. https://doi.org/10.1200/jco.2016.67.4283.CrossRef

29.

Pasquier D, Bataille B, Le Tinier F, Bennadji R, Langin H, Escande A, et al. Correlation between toxicity and dosimetric parameters for adjuvant intensity modulated radiation therapy of breast cancer: a prospective study. Sci Rep. 2021;11:3626. https://doi.org/10.1038/s41598-021-83159-3.CrossRefPubMedPubMedCentral

30.

Pignol JP, Vu TT, Mitera G, Bosnic S, Verkooijen HM, Truong P. Prospective evaluation of severe skin toxicity and pain during postmastectomy radiation therapy. Int J Radiat Oncol Biol Phys. 2015;91:157–64. https://doi.org/10.1016/j.ijrobp.2014.09.022.CrossRefPubMed

31.

Rossi M, Pistelli F, Pesce M, Aquilini F, Franzoni F, Santoro G, et al. Impact of long-term exposure to cigarette smoking on skin microvascular function. Microvasc Res. 2014;93:46–51. https://doi.org/10.1016/j.mvr.2014.03.001.CrossRefPubMed

32.

Izzotti A, Cartiglia C, Longobardi M, Balansky RM, D’Agostini F, Lubet RA et al. Alterations of gene expression in skin and lung of mice exposed to light and cigarette smoke. FASEB journal: official publication of the Federation of American Societies for Experimental Biology. 2004; 18:1559–61. doi:https://doi.org/10.1096/fj.04-1877fje

33.

Pilz AC, Schielein MC, Schuster B, Heinrich L, Haufe E, Abraham S, et al. Atopic dermatitis: disease characteristics and comorbidities in smoking and non-smoking patients from the TREATgermany registry. J Eur Acad Dermatology Venereology: JEADV. 2022;36:413–21. https://doi.org/10.1111/jdv.17789.CrossRef

34.

Oweis AO, Al-Qarqaz F, Bodoor K, Heis L, Alfaqih MA, Almomani R, et al. Elevated interleukin 31 serum levels in hemodialysis patients are associated with uremic pruritus. Cytokine. 2021;138:155369. https://doi.org/10.1016/j.cyto.2020.155369.CrossRefPubMed

35.

Pisoni RL, Wikström B, Elder SJ, Akizawa T, Asano Y, Keen ML, et al. Pruritus in haemodialysis patients: international results from the Dialysis Outcomes and practice patterns study (DOPPS). Nephrology, dialysis, transplantation: official publication of the european Dialysis and Transplant Association -. Eur Ren Association. 2006;21:3495–505. https://doi.org/10.1093/ndt/gfl461.CrossRef

36.

Lin JC, Tsai JT, Chou YC, Li MH, Liu WH. Compared with intensity-modulated radiotherapy, image-guided radiotherapy reduces severity of acute radiation-induced skin toxicity during radiotherapy in patients with breast cancer. Cancer Med. 2018;7:3622–9. https://doi.org/10.1002/cam4.1630.CrossRefPubMedPubMedCentral

37.

Yücel B, Okur Y, Akkas EA, Eren MF. Lack of impact of age on acute side effects and tolerance of curative radiation therapy. Asian Pac J cancer prevention: APJCP. 2013;14:969–75.CrossRef

38.

Sharp L, Johansson H, Hatschek T, Bergenmar M. Smoking as an independent risk factor for severe skin reactions due to adjuvant radiotherapy for breast cancer. Breast. 2013;22:634–8. https://doi.org/10.1016/j.breast.2013.07.047.CrossRefPubMed

39.

Tortorelli G, Di Murro L, Barbarino R, Cicchetti S, di Cristino D, Falco MD, et al. Standard or hypofractionated radiotherapy in the postoperative treatment of breast cancer: a retrospective analysis of acute skin toxicity and dose inhomogeneities. BMC Cancer. 2013;13:230. https://doi.org/10.1186/1471-2407-13-230.CrossRefPubMedPubMedCentral

40.

Cordoba EE, Lacunza E, Guerci AM. Clinical factors affecting the determination of radiotherapy-induced skin toxicity in breast cancer. J radiation Oncol. 2021;39:315–23. https://doi.org/10.3857/roj.2020.00395.CrossRef

41.

Wolcott R, Sanford N, Gabrilska R, Oates JL, Wilkinson JE, Rumbaugh KP. Microbiota is a primary cause of pathogenesis of chronic wounds. J Wound Care. 2016;25:33–s43. https://doi.org/10.12968/jowc.2016.25.Sup10.S33.CrossRef

42.

Pouri M, Shaghaghi Z, Ghasemi A, Hosseinimehr SJ. Radioprotective Effect of Gliclazide as an anti-hyperglycemic Agent Against Genotoxicity Induced by Ionizing Radiation on Human Lymphocytes. Cardiovasc Hematol Agents Med Chem. 2019;17:40–6. https://doi.org/10.2174/1871525717666190524092918.CrossRefPubMedPubMedCentral

43.

Cheki M, Shirazi A, Mahmoudzadeh A, Bazzaz JT, Hosseinimehr SJ. The radioprotective effect of metformin against cytotoxicity and genotoxicity induced by ionizing radiation in cultured human blood lymphocytes. Mutat Res Genetic Toxicol Environ Mutagen. 2016;809:24–32. https://doi.org/10.1016/j.mrgentox.2016.09.001.CrossRef

44.

Fritz G, Henninger C, Huelsenbeck J. Potential use of HMG-CoA reductase inhibitors (statins) as radioprotective agents. Br Med Bull. 2011;97:17–26. https://doi.org/10.1093/bmb/ldq044.CrossRefPubMed

45.

Mahmoudi M, Gorenne I, Mercer J, Figg N, Littlewood T, Bennett M. Statins use a novel Nijmegen breakage syndrome-1-dependent pathway to accelerate DNA repair in vascular smooth muscle cells. Circ Res. 2008;103:717–25. https://doi.org/10.1161/circresaha.108.182899.CrossRefPubMed

46.

Citrin DE, Hitchcock YJ, Chung EJ, Frandsen J, Urick ME, Shield W, et al. Determination of cytokine protein levels in oral secretions in patients undergoing radiotherapy for head and neck malignancies. Radiat Oncol. 2012;7:64. https://doi.org/10.1186/1748-717x-7-64.CrossRefPubMedPubMedCentral

47.

Gallet P, Phulpin B, Merlin JL, Leroux A, Bravetti P, Mecellem H, et al. Long-term alterations of cytokines and growth factors expression in irradiated tissues and relation with histological severity scoring. PLoS ONE. 2011;6:e29399. https://doi.org/10.1371/journal.pone.0029399.CrossRefPubMedPubMedCentral

48.

Rodriguez-Gil JL, Takita C, Wright J, Reis IM, Zhao W, Lally BE, et al. Inflammatory biomarker C-reactive protein and radiotherapy-induced early adverse skin reactions in patients with breast cancer. Cancer Epidemiol Biomarkers Prev. 2014;23:1873–83. https://doi.org/10.1158/1055-9965.EPI-14-0263.CrossRefPubMedPubMedCentral

49.

Ramírez-Carmona W, Díaz-Fabregat B, Yuri Yoshigae A, Musa de Aquino A, Scarano WR, de Souza Castilho AC, et al. Are serum ferritin levels a Reliable Cancer Biomarker? A systematic review and Meta-analysis. Nutr Cancer. 2022;74:1917–26. https://doi.org/10.1080/01635581.2021.1982996.CrossRefPubMed

50.

Shim YS, Kang MJ, Oh YJ, Baek JW, Yang S, Hwang IT. Association of serum ferritin with insulin resistance, abdominal obesity, and metabolic syndrome in korean adolescent and adults: the Korean National Health and Nutrition Examination Survey, 2008 to 2011. Medicine. 2017;96:e6179. https://doi.org/10.1097/md.0000000000006179.CrossRefPubMedPubMedCentral

51.

Lee TF, Sung KC, Chao PJ, Huang YJ, Lan JH, Wu HY, et al. Relationships among patient characteristics, irradiation treatment planning parameters, and treatment toxicity of acute radiation dermatitis after breast hybrid intensity modulation radiation therapy. PLoS ONE. 2018;13:e0200192. https://doi.org/10.1371/journal.pone.0200192.CrossRefPubMedPubMedCentral

Title: Predicting acute radiation dermatitis in breast cancer: a prospective cohort study
Authors: Yuxiu Xie
Ting Hu
Renwang Chen
Haiyan Chang
Qiong Wang
Jing Cheng
Publication date: 01-12-2023
Publisher: BioMed Central
Keywords: Breast Cancer
Breast Cancer
Radiotherapy
Published in: BMC Cancer / Issue 1/2023
Electronic ISSN: 1471-2407
DOI: https://doi.org/10.1186/s12885-023-10821-6

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras

Prof. Fabrice Barlesi

Developed by: Springer Medicine

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Background

Methods

Results

Conclusion

Please log in to get access to this content

Other articles of this Issue 1/2023

The prognostic significance of histologic variant on survival outcomes in patients with metastatic urothelial carcinoma receiving immune checkpoint inhibitor therapy

Family resilience and its influencing factors among advanced cancer patients and their family caregivers: a multilevel modeling analysis

AC010883.5 promotes cell proliferation, invasion, migration, and epithelial-to-mesenchymal transition in cervical cancer by modulating the MAPK signaling pathway

Triple modal treatment comprising with proton beam radiation, hyperthermia, and gemcitabine/nab-paclitaxel for locally advanced pancreatic cancer: a phase I/II study protocol (TT-LAP trial)

Elevated LILRB1 expression predicts poor prognosis and is associated with tumor immune infiltration in patients with glioma

Detection of Human cytomegalovirus UL55 Gene and IE/E Protein Expression in Colorectal Cancer Patients in Egypt

Keynote webinar | Spotlight on antibody–drug conjugates in cancer